Alzheimer's disease - Do tauists and baptists finally shake hands?

Trends in Neurosciences

Volumn 25, Issue 1, 2002, Pages 22-26

  Mudher, Amritpal ^a   Lovestone, Simon ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; DOWNSTREAM PROCESSING; HYPOTHESIS; MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; MICE; NEUROFIBRILLARY TANGLES; PROTO-ONCOGENE PROTEINS; SENILE PLAQUES; SIGNAL TRANSDUCTION; TAU PROTEINS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0036150827     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)02031-2     Document Type: Review

References (57)

1. Alzheimer's disease: The amyloid cascade hypothesis
2. Genes, models and Alzheimer's disease
3. Intracellular APP processing and Aβ production in Alzheimer disease
4. Targeting small Aβ oligomers: The solution to an Alzheimer's disease conumdrum
5. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60
6. Susceptibility locus for Alzheimer's disease on chromosome 10
7. Linkage of plasma Aβ-42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
8. Activation of tau protein kinase I glycogen synthase kinase-3β by amyloid β peptide (25-35) enhances phosphorylation of tau in hippocampal neurons
9. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity
10. Lithium protects cultured neurons against β-amyloid-induced neurodegeneration
11. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
12. Increased amyloid-β42 (43) in brains of mice expressing mutant presenilin 1
13. Age related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins
14. Sw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1
15. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
16. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
17. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease
18. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
19. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
20. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
21. Alzheimer's disease: Paired helical filaments and cytomembranes
22. The phosphorylation of tau: A critical stage in neurodevelopmental and neurodegenerative processes
23. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease
24. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments
25. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: Correlations using three sets of neuropathological criteria
26. Evolution of neuronal changes in the course of Alzheimer's disease
27. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
28. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
29. Untangling tau-related dementia
30. Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients
31. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations
32. The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules
33. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments
34. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations
35. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
36. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation
37. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism - Chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
38. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10
39. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10
40. Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17
41. Competition for microtubule-binding with dual expression of tau missense and splice isoforms
42. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
43. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils
44. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
45. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice
46. Coexisting pathologies in the brain: Influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus
47. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?
48. The role of cerebral ischemia in Alzheimer's disease
49. Does dysregulation of the notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease?
50. Wnt signaling function in Alzheimer's disease
51. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing
52. Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and β-catenin
53. Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
54. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing
55. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
56. Interaction between wingless and notch signaling pathways mediated by dishevelled
57. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase